v3.25.0.1
Restructuring Plans (Tables)
12 Months Ended
Dec. 31, 2024
Restructuring charges  
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for 2024, 2023 and 2022:
(in millions)
Accrued balance as of December 31, 2021$33 
Charges
193 
Payments and other adjustments(50)
Accrued balance as of December 31, 2022176 
Charges
107 
Payments and other adjustments(87)
Accrued balance as of December 31, 2023196 
Charges
168 
Payments and other adjustments(128)
Accrued balance as of December 31, 2024$236 
Allergan integration plan  
Restructuring charges  
Summary of charges associated with integration plan
The following table summarizes the charges associated with the Allergan acquisition integration plan:
year ended December 31 (in millions)20232022
Cost of products sold$89 $117 
Research and development23 
Selling, general and administrative192 399 
Total charges $288 $539